Sertraline plus a probiotic (Lactobacillus crispatus) for teens with depression
Official title: Efficacy and Safety of Sertraline Combined With Lactobacillus Crispatus in Adolescents With Depression : A Multicenter Randomized Controlled Trial
Run by First Affiliated Hospital of Chongqing Medical University · NCT07539805 · Data updated 2026-11-12
This study tests whether adding Lactobacillus crispatus to sertraline helps reduce depressive symptoms in adolescents with major depressive disorder.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 12 Years to 18 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | First Affiliated Hospital of Chongqing Medical University Academic / other |
| Locations | 2 sites (Longgang, Chongqing Municipality and 1 other locations) |
| Status | Recruiting |
| Started | June 11, 2026 |
| Main results expected | February 2028 |
| Study ends | April 2028 |
| Registry record updated | June 15, 2026 |
| Trial ID | NCT07539805 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are 12–18 years old with DSM-5–confirmed MDD, CDRS-R ≥40, and CGI-S ≥4 who have not responded to two prior antidepressants.
✕Probably not a fit
Patients with certain comorbid psychiatric or neurological conditions or those who do not respond to sertraline may not benefit from the probiotic addition.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The trial enrolls adolescents aged 12–18 with major depressive disorder who receive sertraline and are randomized to also receive either Lactobacillus crispatus or a placebo for 8 weeks. Participants visit the clinic every 4 weeks for safety checks and symptom assessments. The goal is to see if the probiotic combination provides greater improvement in mood and emotional symptoms than sertraline with placebo. The study excludes individuals with certain comorbid psychiatric or neurological conditions and those with inadequate antidepressant response history. The lead sponsor is the First Affiliated Hospital of Chongqing Medical University, with sites in Chongqing, China.
Why it matters
Potential benefit: If successful, the combination could offer an additional way to improve depressive symptoms in adolescents.
How similar studies have gone: Previous research in adults has explored probiotics for mood disorders, but results in adolescents are limited and this specific combination is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria * Aged 12-18 years * Meets DSM-5 criteria for major depressive disorder (MDD) and is currently in a depressive episode according to the Kiddie Schedule for Affective Disorders and Schizophrenia - Present and Lifetime Version (K-SADS-PL) interviews * Child Depression Rating Scale-Revised (CDRS-R) score ≥40 at baseline * Clinical Global Impression Scale (CGI-S) score ≥ 4 at baseline Exclusion criteria * Presence of any comorbid psychiatric disorder according to DSM-5, other than anxiety disorders * MDD with psychotic symptoms * Young Mania Rating Scale (YMRS) \>13 at baseline * History of neurological disorders (e.g., epilepsy, traumatic brain injury), or the presence of serious physical illnesses (e.g., thyroid disease, lupus erythematosus, diabetes mellitus, clinically significant pulmonary, hepatic, or renal impairment, or major trauma) * Nonresponse to at least two antidepressants with different mechanisms, and each administered at an adequate dose and for an adequate duration * History of intolerance to sertraline or nonresponse to an adequate therapeutic course of sertraline * Current high suicide risk * History of alcohol or drug abuse or dependence * Taking or administering antidepressants within 5 half-lives * Use of probiotic-related food or medicine within 2 weeks before enrollment * Systemic use of antibiotics or antifungals within 1 month before enrollment * History of severe food allergy or known hypersensitivity to the Lactobacillus crispatus preparation or any of its components * Adherence to vegetarian or other restrictive dietary patterns * Pregnancy or breastfeeding
Where it's running
-
The Affiliated Hospital of Chongqing Medical University
Chongqing, Yuzhong, China Recruiting -
The Affiliated Dazu's Hospital of Chongqing Medical University
Longgang, Chongqing Municipality, China Not yet recruiting
Study contacts
- Study coordinator: Teng Teng
- Email: tengteng@hospital.cqmu.edu.cn
- Phone: +86 18883368354
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sertraline with multi-strain probiotics for adolescents with depression
This study tests whether adding multi-strain probiotics to sertraline helps teens (ages 12–18) with major depressive disorder feel better than sertraline with a placebo.
-
Emotional Reactivity in Severe Alcohol Use Disorder and Depression Using Eye-Tracking and Physiological Measures
This study tests how people with severe alcohol use disorder, major depressive disorder, both conditions, or neither, recognize and react to emotions using eye-tracking and physiological data.
-
Temporally Interfering Electrical Stimulation for Major Depressive Disorder
This study tests whether noninvasive temporally interfering electrical stimulation can help people with major depressive disorder.
-
Affective Cognitive Training for mood disorders and their close relatives
A six-week program combining virtual reality and computer exercises tests whether affective cognitive training helps people with mood disorders and their unaffected first-degree relatives.
-
ALKS 7290 added to antidepressants for adults with major depression
This study tests whether ALKS 7290, taken with current antidepressants, helps adults with major depressive disorder.
-
French Minds: a French, Multimodal Cohort Study of Severe Psychiatric Disorders and Healthy Controls
This study tests whether people with mood, psychotic, or autism disorders can be grouped into more similar subtypes based on social withdrawal and anhedonia, across ages 15 to 60.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.